JobCannon
全部技能

EMA Approval Process

⬢ 層級 2領域
中等
薪資影響
6 個月
學習時長
困難
難度
1
職業
一覽

The EMA (European Medicines Agency) oversees approval of drugs, vaccines, and medical devices in Europe. The approval process is highly regulated with multiple phases (pre-clinical, clinical trials, dossier submission, review). EMA approval is required to market pharmaceuticals across EU countries. Learning the process takes 4-6 months for someone with pharma background; mastery (running successful approvals) takes 2-3 years. Regulatory managers earn €70-120K because they prevent costly delays, each month of delay costs companies €5-15M in lost sales.

什麼是 EMA Approval Process

The EMA (European Medicines Agency) is the regulatory body responsible for approving human and veterinary medicines across European Union member states. The approval process requires pharmaceutical companies to submit comprehensive dossiers demonstrating safety, efficacy, and quality. These dossiers contain preclinical studies (lab and animal tests), clinical trial results (human testing), manufacturing information, and risk management plans. The EMA operates multiple review pathways. The centralized procedure is fastest: a single EMA committee reviews globally and issues one approval valid across all EU countries. Decentralized and mutual recognition procedures involve multiple national regulators and take longer. Once approved, companies must maintain compliance, report adverse events, and update safety data annually.

🔧 工具與生態
eCTD (electronic Common Technical Document)EudraLex guidance documentsClinical trial management softwareRegulatory information managementQuality Overall Summary documents

💰 各地區薪資

地區初級中級高級
USA$75,000$120,000$180,000
UK£50,000£80,000£120,000
EU€55,000€90,000€140,000
CANADACA$80,000CA$130,000CA$190,000

🎯 使用 EMA Approval Process 的職業

Regulatory Affairs Specialist

❓ 常見問題

What's the difference between centralized, decentralized, and mutual recognition procedures?
Centralized: Single EMA review, valid across all EU. Faster for most drugs (60 days assessment). Decentralized: One EU country leads, others follow. Mutual recognition: Parallel applications in multiple countries. Choose centralized for innovative drugs, decentralized for generic/routine.
How long does EMA approval actually take?
Standard review: 210 days (6-7 months). Accelerated review: 150 days if drug addresses unmet need. PRAC assessment (post-market safety): can add 30-90 days. Total from first submission to approval: typically 8-14 months including revisions.
What gets a company a PRAC review hold?
Safety signals in pre-clinical or Phase 2 data. Unexplained serious adverse events. Lack of genotoxicity data. Manufacturing issues. EMA sends Major Objections (MOs); company must respond with data/analysis. Average 2-3 rounds of MOs before approval.
Can I appeal an EMA rejection?
Yes, via appeal procedure. File formal appeal document + new data within 60 days. Takes 6-9 months. Success rate: ~20% (only if new evidence is compelling). Usually better to redesign the drug or run more trials.
What's a Risk Management Plan and when is it required?
RMP identifies safety risks and mitigation strategies. Required for all EMA submissions. Identifies known risks (from trials), unknown risks (will monitor post-market), and risk mitigation (restrictions, monitoring, education). Updated every 5 years.

不確定這項技能適不適合你？

做一下職業匹配，我們會推薦合適的方向。

找到最適合我的技能 →

找到理想的職業方向

在 2,521 個職業中進行技能匹配。免費。

免費做職業匹配 →